Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
What Are the Projected Market Size and Growth Rates for the Hormonal Intrauterine Devices (IUDs) Market From 2025 To 2029?
The market size of hormonal intrauterine devices (IUDs) has seen impressive growth recently. The market, which was worth $2.61 billion in 2024, is expected to increase to $2.89 billion in 2025 with a compound annual growth rate (CAGR) of 11.0%. This substantial growth during the historic period can be accredited to the evolution of safer and more efficient hormonal formulations, an upsurge in the demand for long-term contraception solutions, an increase in healthcare provider recommendations, heightened public understanding of birth control options, and progress in medical technology and device design.
What Is the Projected Market Size of the Hormonal Intrauterine Devices (IUDs) Market?
The market for hormonal intrauterine devices (IUDs) is predicted to undergo substantial expansion in the coming years. The market will escalate to $4.34 billion by 2029, with a compound annual growth rate (CAGR) of 10.7%. Factors such as increasing consciousness about birth control options, a growing fondness for durable reversible contraception, progress in device reliability and effectiveness, a heightened focus on individualized healthcare and broader access via healthcare professionals, all contribute to this expected growth in the forecast period. Crucial trends during this period will comprise of technological advancements in devices, personalized contraception choices, the surge of patient-oriented healthcare strategies, an increased call for green and eco-friendly products and creation of novel contraceptive items.
Download The Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=19091&type=smp
Who are the Major Competitors in the Hormonal Intrauterine Devices (IUDs) Market Outlook?
Major companies operating in the hormonal intrauterine devices (IUDs) market are Merck & Co. Inc., AbbVie Inc., Bayer AG, Organon & Companies, Gedeon Richter Plc, Meril Life Science Pvt Ltd., Bharat Serums and Vaccines Limited, Teva UK Limited, EurimPharm Produktions GmbH, HRA Pharma SAS, Medicines360, Hll Lifecare Limited, Pregna International Ltd., Allergan plc, Actavis Inc., DKT WomanCare Global, CrossBay Medical Inc., SMB Corporation of India, Oy Leiras, OCON Healthcare
What Is Fueling Growth in the Hormonal Intrauterine Devices (IUDs) Market?
The hormonal intrauterine devices market is expected to grow due to a rise in unwanted pregnancies. Unwanted pregnancies are those that were unplanned or not wanted at the time they were conceived. Reasons for such pregnancies include contraceptive failure, limited access to birth control methods, misuse of contraception, and incidents of sexual violence. Lack of access to effective contraception methods makes more people prone to unwanted pregnancies as it diminishes their ability to manage their reproductive choices effectively. Hormonal IUDs are lauded for their efficacy in preventing pregnancies, boasting a failure rate of less than 1%. They offer long-lasting protection that can last between 3 and 7 years, depending on the type of IUD, proving them a dependable choice for those wanting to prevent unwanted pregnancies. For example, in August 2023, the Office for Health Improvement & Disparities, a governmental organization in the UK under the Department of Health and Social Care, reported that from January to June 2022, there were 123,219 abortions performed in England and Wales, indicating a 17% rise compared to the same timeframe in 2021. Consequently, the growth of the hormonal intrauterine devices market is being spurred by the rise in unwanted pregnancies.
Request For A Customized Report:
https://www.thebusinessresearchcompany.com/customise?id=19091&type=smp
Which Hormonal Intrauterine Devices (IUDs) Market Segments Are Growing the Fastest?
The hormonal intrauterine devices (IUDs) market covered in this report is segmented –
1) By Type: 13 Milligram Hormonal Intrauterine Devices, 19 Milligram Hormonal Intrauterine Devices, 52 Milligram Hormonal Intrauterine Devices
2) By Device Design: Framed Intrauterine Devices, Frameless Intrauterine Devices
3) By Hormone Type: Levonorgestrel Releasing Intrauterine Devices, Progesterone Releasing Intrauterine Devices
4) By Application: Age 20-24, Age 25-34, Age 35-44, Other Applications
Subsegments:
1) By 13 Milligram Hormonal Intrauterine Devices: Low-Dose 13 Mg IUDs, Specialty 13 Mg IUDs For Specific Conditions
2) By 19 Milligram Hormonal Intrauterine Devices: Low-Dose 19 Mg IUDs, Specialty 19 Mg IUDs For Specific Conditions
3) By 52 Milligram Hormonal Intrauterine Devices: Standard 52 Mg IUDs, Extended-Release 52 Mg IUDs, Specialty 52 Mg IUDs For Heavy Menstrual Bleeding Or Endometriosis
Which Industry Trends Are Shaping the Future of the Hormonal Intrauterine Devices (IUDs) Market?
Key players in the hormonal intrauterine devices sector are concentrating on the creation of cutting-edge goods such as levonorgestrel-releasing intrauterine systems to provide more tailored contraceptive choices for women. These systems, also known as LNG-IUS, are hormonal intrauterine devices that consistently deliver levonorgestrel, an artificial progestin, to the uterus, thickening cervical mucus and transforming the uterine lining to hinder sperm from contacting the egg. For example, Medicines360, a pharmaceutical firm in the United States dedicated to enhancing women’s access to critical medicines and healthcare products, launched LILETTA, approved by the U.S. Food and Drug Administration (FDA) in November 2022. LILETTA is among the most durable hormonal IUDs available in the United States, with approval for up to 8 years of contraception and up to 5 years for addressing heavy menstrual bleeding. The device has an approximately 99% success rate in preventing pregnancy among various populations. It comes with a user-friendly inserter for ease of fitting on the day of consultation and can be removed at any point by a healthcare professional. It can be obtained via prescription and is offered at a lower price through the 340B drug pricing scheme, reflecting Medicines360’s commitment to improving access to women’s healthcare.
Access The Full Report Here:
Which Countries Are Leading the Hormonal Intrauterine Devices (IUDs) Market?
North America was the largest region in the hormonal intrauterine devices (IUDs) market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the hormonal intrauterine devices (IUDs) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Purchase The Full Report Today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=19091
This Report Delivers Insight On:
1. How big is the hormonal intrauterine devices (iuds) market, and how is it changing globally?
2. Who are the major companies in the hormonal intrauterine devices (iuds) market, and how are they performing?
3. What are the key opportunities and risks in the hormonal intrauterine devices (iuds) market right now?
4. Which products or customer segments are growing the most in the hormonal intrauterine devices (iuds) market?
5. What factors are helping or slowing down the growth of the hormonal intrauterine devices (iuds) market?
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 2071930708
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model